Related Experiment Video
Updated: Mar 31, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
cFLIP expression is altered in severe corticosteroid-resistant asthma.
Dennis Lazarev1, Rachel L Miller2, Emily Dimango3
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Alternative splicing changes in asthma were investigated. Researchers found altered cFLIP expression in severe, corticosteroid-resistant asthma, suggesting apoptosis pathway dysregulation in disease pathogenesis.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- Dysregulation of messenger RNA (mRNA) alternative splicing is implicated in various human diseases.
- Alternative splicing plays a critical role in regulating gene expression and protein diversity.
Purpose of the Study:
- To conduct the first systematic search for asthma-associated alternative splicing events.
- To investigate the role of cFLIP (a modulator of apoptosis) in asthma pathogenesis.
Main Methods:
- Utilized a mouse model sensitized to Aspergillus fumigatus (A. fumigatus).
- Employed an exon junction microarray to detect alternative splicing changes.
- Analyzed cFLIP isoform expression in human asthma patients.
Main Results:
- Identified sensitization-associated alternative splicing shifts in cFLIP mRNA in a mouse model.
- Observed a significant decrease in both cFLIP isoforms in severe, corticosteroid-resistant human asthmatics.
- Found evidence linking cFLIP dysregulation to the immunopathogenesis of severe refractory asthma.
Conclusions:
- Dysregulation of the extrinsic apoptosis pathway is implicated in severe refractory asthma.
- Altered cFLIP expression may contribute to the immunopathogenesis of severe asthma.
- Further research is needed to fully elucidate the role of alternative splicing in asthma.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
COPD: Management Using Bronchodilators and Corticosteroids